NH Narayana Hrudayalaya Q4 FY25 results (Jan–Mar 2025) and concall
Narayana Hrudayalaya reported a strong Q4 FY25 with 11% overall revenue growth and 14-15% growth in its India business (ex-international patients). The Cayman business achieved robust 45% margins, establishing a new $45 million revenue base. While India EBITDA margins improved due to cost controls and better payor mix, the integrated care and insurance segments recorded a loss of INR 65 crores for FY25, with further losses anticipated as these segments expand. Working capital days also saw an increase due to delayed government payor settlements.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 1,367 | 1,335 | 1,475 |
| EBITDA | 309 | 307 | 358 |
| Net profit | 199 | 193 | 197 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
